Petragen, Inc.

SEC filing

Biotechnology · Davie, FL

Form D on EDGAR

Amount raised$495Ksold at filing

Total offering$1M$505K still open

Investors in the raise9count reported to the SEC

FiledJun 23, 2026first sale Apr 5, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Demetrios Braddock, MD, PhDExecutive Officer

David KolbExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.